221 related articles for article (PubMed ID: 24911000)
1. Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Pritchard AJ; Mir AK; Dev KK
PLoS One; 2014; 9(6):e99444. PubMed ID: 24911000
[TBL] [Abstract][Full Text] [Related]
2. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
Miron VE; Ludwin SK; Darlington PJ; Jarjour AA; Soliven B; Kennedy TE; Antel JP
Am J Pathol; 2010 Jun; 176(6):2682-94. PubMed ID: 20413685
[TBL] [Abstract][Full Text] [Related]
3. Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors.
O'Sullivan SA; Velasco-Estevez M; Dev KK
Glia; 2017 Jul; 65(7):1119-1136. PubMed ID: 28375547
[TBL] [Abstract][Full Text] [Related]
4. The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
O'Sullivan C; Schubart A; Mir AK; Dev KK
J Neuroinflammation; 2016 Feb; 13():31. PubMed ID: 26856814
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia.
O'Sullivan SA; O'Sullivan C; Healy LM; Dev KK; Sheridan GK
J Neurochem; 2018 Mar; 144(6):736-747. PubMed ID: 29377126
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod modulates microglial activation to augment markers of remyelination.
Jackson SJ; Giovannoni G; Baker D
J Neuroinflammation; 2011 Jul; 8():76. PubMed ID: 21729281
[TBL] [Abstract][Full Text] [Related]
7. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Sheridan GK; Dev KK
Glia; 2012 Mar; 60(3):382-92. PubMed ID: 22108845
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Alme MN; Nystad AE; Bø L; Myhr KM; Vedeler CA; Wergeland S; Torkildsen Ø
J Neuroimmunol; 2015 Aug; 285():180-6. PubMed ID: 26198937
[TBL] [Abstract][Full Text] [Related]
9. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
10. Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling.
O'Sullivan C; Dev KK
J Cell Sci; 2015 Nov; 128(21):3878-87. PubMed ID: 26359302
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
di Penta A; Moreno B; Reix S; Fernandez-Diez B; Villanueva M; Errea O; Escala N; Vandenbroeck K; Comella JX; Villoslada P
PLoS One; 2013; 8(2):e54722. PubMed ID: 23431360
[TBL] [Abstract][Full Text] [Related]
13. Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes.
Healy LM; Sheridan GK; Pritchard AJ; Rutkowska A; Mullershausen F; Dev KK
Br J Pharmacol; 2013 Jul; 169(5):1114-29. PubMed ID: 23587004
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Hla T; Brinkmann V
Neurology; 2011 Feb; 76(8 Suppl 3):S3-8. PubMed ID: 21339489
[TBL] [Abstract][Full Text] [Related]
15. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Blanc CA; Rosen H; Lane TE
J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
[TBL] [Abstract][Full Text] [Related]
16. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
[TBL] [Abstract][Full Text] [Related]
17. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
18. Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
Peschl P; Schanda K; Zeka B; Given K; Böhm D; Ruprecht K; Saiz A; Lutterotti A; Rostásy K; Höftberger R; Berger T; Macklin W; Lassmann H; Bradl M; Bennett JL; Reindl M
J Neuroinflammation; 2017 Oct; 14(1):208. PubMed ID: 29070051
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis.
Rau CR; Hein K; Sättler MB; Kretzschmar B; Hillgruber C; McRae BL; Diem R; Bähr M
Am J Pathol; 2011 Apr; 178(4):1770-81. PubMed ID: 21406175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
